TOFEZV-ER

Category : Tablets

TOFEZV-ER is an advanced therapeutic formulation containing Tofacitinib in an Extended Release (ER) format, specifically engineered to provide a controlled and sustained delivery of the medication over a 24-hour period. As a potent Janus Kinase (JAK) inhibitor, it is highly effective in managing chronic inflammatory conditions such as rheumatoid arthritis and psoriatic arthritis by consistently modulating the body's immune response. The once-daily extended-release dosage improves patient compliance compared to standard formulations, offering steady blood plasma levels that ensure long-lasting relief from joint inflammation, pain, and stiffness while maintaining superior safety and efficacy standards.

Composition:

Tofacitinib IP 11mg

Packing:
10 X 10
MRP:
On Request